Two therapeutic challenges: Facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream

dc.contributor.authorBilaç D.B.
dc.contributor.authorErmertcan A.T.
dc.contributor.authorŞahin M.T.
dc.contributor.authorÖztürkcan S.
dc.date.accessioned2024-07-22T08:22:05Z
dc.date.available2024-07-22T08:22:05Z
dc.date.issued2009
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1111/j.1468-3083.2008.02668.x
dc.identifier.issn14683083
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18918
dc.language.isoEnglish
dc.subjectAdolescent
dc.subjectCalcitriol
dc.subjectDermatologic Agents
dc.subjectFemale
dc.subjectHumans
dc.subjectImmunosuppressive Agents
dc.subjectTacrolimus
dc.subjectVitiligo
dc.subjectcalcipotriol
dc.subjectpimecrolimus
dc.subjectadolescent
dc.subjectanamnesis
dc.subjectcase report
dc.subjectclinical feature
dc.subjectdepigmentation
dc.subjectdrug efficacy
dc.subjectface
dc.subjectfemale
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthypopigmentation
dc.subjectletter
dc.subjectpriority journal
dc.subjectskin examination
dc.subjecttreatment response
dc.subjectvitiligo
dc.titleTwo therapeutic challenges: Facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream
dc.typeLetter

Files